Pivotal
Pivotal studies play a critical role in demonstrating the safety and efficacy of investigational therapies before regulatory submission. CenExel partners with sponsors to execute high-quality Phase III and late-stage clinical trials, delivering operational excellence, robust patient recruitment, and reliable data that support successful regulatory outcomes.


Studies Conducted
Trial Participants
Active Sites
Leading Excellence in Pivotal Clinical Research
CenExel's integrated research network provides sponsors with the infrastructure, expertise, and patient access needed to successfully execute pivotal clinical trials. Our experienced investigators and dedicated site teams ensure protocol compliance, high-quality data collection, and efficient study delivery.
From complex therapeutic indications to large-scale enrollment initiatives, we help sponsors navigate the critical path toward regulatory approval with confidence and precision.
Our centralized operational model enables consistency across sites while maintaining flexibility to meet unique protocol requirements and study objectives.
Therapeutic Areas Supported Through Pivotal Studies
Our pivotal research capabilities extend beyond recruitment, delivering scientific rigor, efficient execution, and dependable results that support critical development milestones.
Central Nervous System (CNS)
Psychiatry & Behavioral Health
Pain Management
Metabolic Disorders
Cardiovascular Diseases
Gastroenterology
Rare Diseases
Women's Health
Infectious Diseases
Dermatology
Why Sponsors Choose CenExel for Pivotal Studies
We partner with sponsors throughout pivotal studies, offering clinical expertise, operational efficiency, and reliable performance to accelerate the path to approval.
01
Proven Regulatory Readiness
Extensive experience supporting studies designed for regulatory submissions and approval pathways.
02
Large Patient Recruitment Network
Access to diverse patient populations through a nationwide network of specialized research centers.
03
Consistent Data Quality
Standardized operational processes ensure reliable data collection and protocol adherence.
04
Scalable Study Execution
Integrated infrastructure supports large, multicenter pivotal trials across multiple therapeutic areas.
Supported Trial Phases
We support clinical development from early-phase proof-of-concept studies through large-scale pivotal trials and post-marketing research.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Late-stage and pivotal studies remain a core strength of the CenExel network, helping sponsors advance promising therapies toward commercialization and patient access.
Pivotal Studies Task Force
CenExel's Pivotal Studies Task Force brings together experienced investigators, operational leaders, and therapeutic experts to support complex late-stage clinical programs. The team focuses on accelerating enrollment, maintaining data quality, optimizing site performance, and ensuring successful execution across multicenter studies.
Active Sites
15 Sites
Also in Pain & Inflammation
